COMPOUNDS / STEROID / OXANDROLONE
STEROID

OXANDROLONE

MEDIUM RISK
BEST FOR:Recovery●●●●●●●○○○7/10
OXANDROLONE · ANAVAR · OXANDRIN · LONAVAR · OXANDRIN · VASOROME · ANTITRIOL · LIPIDEX · OXANDROLONA
Anabolic SteroidOral 17-AlphaBurn RecoveryWound HealingDHT DerivativeHepatotoxic

Synthetic oral anabolic steroid used clinically for burn recovery, wound healing, and growth promotion; mild androgenic profile with high oral bioavailability.

ROUTE / DOSAGE
LOW2.5mg
STANDARD5-10mg
HIGH20-80mg
Note: Medical dosing 2.5-20mg/day; performance users often exceed 40mg/day which increases hepatotoxicity risk
CYCLE
6-8 weeks typical max 12 weeks liver enzymes monitored throughout
BIOAVAILABILITY
~97% oral
ACTIVE DURATION
8-12 hours per dose anabolic effects cumulative over weeks (subjective)
STORAGE
Room temperature (15-30°C) dry away from light keep tablets in original container
HALF-LIFE
9-10 hours (plasma)
DURATION BREAKDOWN
Total8-12 hours pharmacologically active per dose; clinical effects over weeks
Onset1-2 hours (plasma); days for measurable anabolic effects
Come upDays to weeks for anabolic adaptation
Peak2-4 weeks of continuous use
OffsetDays after discontinuation (plasma clearance)
After effectsWeeks to months for HPTA recovery and lipid normalization
Duration varies by route, dose, and individual. Source: community reports.
§ 01 — EFFECTS
6 documented
Increased lean body mass
Enhanced wound healing
Reduced protein catabolism
Improved bone mineral density
Increased strength
Mild androgenic effects
§ 02 — RISKS
Hepatotoxicity including transaminase elevation and rare cholestasis (17-alpha alkylated)
Virilization in females (voice deepening, hirsutism, clitoromegaly)
Suppression of endogenous testosterone and HPTA dysfunction
Adverse lipid changes (decreased HDL, increased LDL)
Potential liver enzyme elevation requiring monitoring
No mortality benefit demonstrated in burn populations
§ 03 — INTERACTIONS
Interaction data not yet available for this compound.
§ 04 — SCIENCE

Multiple meta-analyses confirm oxandrolone reduces hospital length of stay, improves weight regain, increases lean body mass, and accelerates donor-site wound healing in severe burn patients. A 2025 meta-analysis of 14 RCTs (n=2822) showed significant reductions in surgical procedures and LOS/TBSA alongside enhanced anabolic recovery, but no mortality benefit and elevated transaminase levels in adults (19% vs 5% placebo, p=0.002). In Turner syndrome, oxandrolone added to growth hormone therapy yielded a modest 2.7 cm increase in final adult height (moderate-quality evidence). Evidence for pressure ulcer wound healing is weak, limited to a single low-certainty study. No trial has demonstrated a mortality benefit in any population.

§ 06 — SOURCES
[1]
Oxandrolone - Plast Reconstr Surg 2006
pubmed.ncbi.nlm.nih.gov ↗
[2]
A Reappraisal of Oxandrolone in Burn Management - J Pharm Technol 2022
pubmed.ncbi.nlm.nih.gov ↗
[3]
Oxandrolone in the Treatment of Burn Injuries: Systematic Review and Meta-analysis - J Burn Care Res 2020
pubmed.ncbi.nlm.nih.gov ↗
[4]
Oxandrolone Efficacy in Wound Healing in Burned and Decubitus Ulcer Patients - Cureus 2022
pubmed.ncbi.nlm.nih.gov ↗
[5]
Oxandrolone for growth hormone-treated girls with Turner syndrome - Cochrane 2019
pubmed.ncbi.nlm.nih.gov ↗
[6]
Oxandrolone for burn patients: updated meta-analysis 2005-2025 - World J Emerg Surg 2025
pubmed.ncbi.nlm.nih.gov ↗
[7]
Burn-induced hypermetabolism and skeletal muscle dysfunction - Am J Physiol Cell Physiol 2021
pubmed.ncbi.nlm.nih.gov ↗
[8]
Oxandrolone use in adult burn patients: Systematic review and meta-analysis - Acta Cir Bras 2014
pubmed.ncbi.nlm.nih.gov ↗
Disclaimer. Protokol.wiki is an informational reference. Nothing on this site is medical advice. Compounds listed may be unapproved, unregulated, or illegal in your jurisdiction. Consult a licensed physician before use. Data compiled from peer-reviewed literature.
METHODOLOGYCONTRIBUTECONTACT